By
AmyT on
January 17, 2012
In the area of beta cell preservation, there’s a (sort of) new name in the spotlight: Andromeda Biotech, Ltd. with its DiaPep277 treatment. Based in Israel, this company announced last month that phase III clinical trials showed significant preservation of C-peptide levels, a marker for assessing insulin secretion by pancreatic cells. Andromeda joins the ranks of companies like Tolerx and Macrogenics/Lilly, who’ve been vocal about their work to preserve beta cell functioning in newly diagnosed patients…
Read more »
By
AmyT on
October 19, 2011
For the next few days, the diabetes the online community is rallying around “LADA Awareness Week” to call attention to Latent Autoimmune Diabetes in Adults. This is obviously the type that turned my own life upside-down.
We know there’s some controversy about the specific definition of this type of diabetes (see my own definition post + comments), so we decided to query some leading experts from around the country for their thoughts on this nebulous…
Read more »
Richard Vaughn is a bit of a legend in the diabetes online community. Known more widely as Richard157 on several diabetes forums, Richard began sharing his story of living with type 1 diabetes for over 60 years via forum posts in 2007 and has become an inspiration for many. Last week, Richard also became a self-published author, releasing his memoirs, Beating The Odds: 64 Years of Diabetes Health, on Amazon.com.
Born in 1939 in rural…
Read more »
By
AmyT on
December 6, 2007
Allie Beatty, formerly of TheDiabetesBlog, has established a new multimedia site “Allies Voice” where she has launched a crusade. The issue at stake is a substance called C-peptide, which in a healthy body, is present in tandem with insulin, but is removed during the manufacturing process of human insulin analogs that we PWDs must inject. Allie and others believe that Big Pharma is doing Type 1 patients a grave disservice by removing this substance, and…
Read more »
